Noah Goodman

Insider Reports History

Location
Watertown, MA
Signature
/s/ Bruce Jacobs, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Noah Goodman:

Company Role Class Num Shares Value Price $ Report Date Ownership
Kymera Therapeutics, Inc. Chief Business Officer Common Stock 59,306 $4,982,926 $84.02 02 Mar 2026 Direct
Kymera Therapeutics, Inc. Chief Business Officer Stock Option (Right to Buy) 18,450 02 Mar 2026 Direct

Insider Reports Filed by Noah Goodman

Symbol Company Period Transactions Value $ Form Type Role Filing Time
KYMR Kymera Therapeutics, Inc. 02 Mar 2026 2 $0 4 Chief Business Officer 04 Mar 2026, 18:00
KYMR Kymera Therapeutics, Inc. 08 Apr 2025 2 $0 4 Chief Business Officer 09 Apr 2025, 08:05
KYMR Kymera Therapeutics, Inc. 08 Apr 2025 0 $0 3 Chief Business Officer 09 Apr 2025, 08:00